[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349910-105":59,"doc-detail-349910-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-machine-learning-and-molecular-docking-reveal-narirutin-targets-abcc1abcg2-for-immune-microenvironment-remodeling-in-colorectal-cancer","Integrative machine learning and molecular docking reveal Narirutin targets ABCC1/ABCG2 for immune microenvironment remodeling in colorectal cancer","","Integrative computational analyses identify narirutin as a candidate agent for colorectal cancer (CRC) by uncovering its key targets and mechanisms within the immune microenvironment. Differential expression and enrichment analyses (GO/KEGG) on TCGA-COAD intersecting genes combined with machine learning pinpoint hub genes, including ABCC1 and ABCG2. Molecular docking evaluates favorable binding affinities between narirutin and predicted target proteins. Immune infiltration analysis highlights CRC–control immune cell composition differences, supporting narirutin’s potential to remodel tumor microenvironment dynamics.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-machine-learning-and-molecular-docking-reveal-narirutin-targets-abcc1abcg2-for-immune-microenvironment-remodeling-in-colorectal-cancer/349910/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-machine-learning-and-molecular-docking-reveal-narirutin-targets-abcc1abcg2-for-immune-microenvironment-remodeling-in-colorectal-cancer/349910.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main objective regarding narirutin and colorectal cancer?","Question",{"text":112,"@type":113},"To identify key targets and potential mechanisms of narirutin in colorectal cancer using bioinformatics analysis and machine learning approaches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which target genes are highlighted as key narirutin targets?",{"text":117,"@type":113},"The study reports narirutin targets key genes including ABCC1, ABCG2, CA12, EPHX2, and PTGS1, which are involved in CRC progression.",{"name":119,"@type":110,"acceptedAnswer":120},"How are binding interactions between narirutin and target proteins assessed?",{"text":121,"@type":113},"Molecular docking is performed to evaluate binding affinities between narirutin and its predicted target proteins, showing favorable binding results.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349910,1790257315,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIntegrative machine learning and molecular docking reveal Narirutin targets ABCC1/ABCG2 for immune microenvironment remodeling in colorectal cancer  \nRuiqi Bian1, Hanlin Wang2, Hui Zhang2, Huajie Tian2, Chunlei Qu2, Aihong Zhao2 & Fei Chen2􀀍  \nColorectal cancer (CRC) is one of the most prevalent and deadly cancers worldwide, with latestage diagnosis often associated with poor prognosis. The natural compound narirutin has shown various biological activities, including anti-inflammatory and anti-cancer effects, indicating its potential clinical application. This study aims to identify the key targets and potential mechanisms of narirutin treatment in colorectal cancer (CRC) through comprehensive bioinformatics analysis and machine learning methods, emphasizing its importance as a potential therapeutic agent. We utilized SwissTargetPrediction to identify 23 target genes of narirutin, followed by differential expression analysis of 3,338 genes from theTCGA-COAD dataset. We performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses on the intersecting genes, and machine learning techniques to identify hub genes. Additionally, we conducted molecular docking studies and immune infiltration analyses. Our findings revealed that narirutin targets key genes, including ABCC1, ABCG2, CA12, EPHX2, and PTGS1, which are significantly involved inCRC progression. Enrichment analyses indicated that these genes participate in crucial pathways related to drug metabolism and immune response. Molecular docking results demonstrated favorable binding affinities between narirutin and its target proteins. Furthermore, immune cell infiltration analysis showed significant differences in various immune cell types between CRC and control groups, suggesting their role in tumor microenvironment dynamics. Narirutin may play a vital role inCRC treatment by modulating key genes and pathways, underscoring its potential as a therapeutic agent. Future studies should explore its clinical applicability and mechanisms further.  \nKeywords Colorectal cancer, Narirutin, Bioinformatics, Machine learning, Immune infiltration  \nColorectal cancer (CRC) is a significant global health concern, being the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide, with an estimated 1.9 million new cases and 935,000 deaths in 2020 alone1 ([https://pubmed.ncbi.nlm.nih.gov/36604116/](https://pubmed.ncbi.nlm.nih.gov/36604116/)). Risk factors for CRC include age, family history, dietary habits, and certain genetic predispositions, making it a multifactorial disease that poses a considerable burden on healthcare systems2 ([https://pubmed.ncbi.nlm.nih.gov/30931583/](https://pubmed.ncbi.nlm.nih.gov/30931583/)).  \nCurrent treatment strategies for CRC primarily involve surgical resection, chemotherapy, and targeted therapies. Traditional chemotherapeutic agents, such as 5-fluorouracil and oxaliplatin, have been widely used; however, their effectiveness is often limited by adverse side effects and the development of drug resistance3 ([https://pubmed.ncbi.nlm.nih.gov/38234802/](https://pubmed.ncbi.nlm.nih.gov/38234802/)). Moreover, targeted therapies, including monoclonal antibodies like cetuximab and bevacizumab, have shown promise in improving patient outcomes but are not universally effective and can be associated with significant costs and side effects4 ([https://pubmed.ncbi.nlm.nih.gov/3534](https://pubmed.ncbi.nlm.nih.gov/3534)[ ](https://pubmed.ncbi.nlm.nih.gov/3534)[2762/](2762/)). Recent studies have explored the potential of natural compounds, such as narirutin, a flavonoid found in citrus fruits, which has demonstrated anti-cancer properties in preclinical models, suggesting a possible adjunctive role in CRC management 5 ([https://pubmed.ncbi.nlm.nih.gov/30544686/](https://pubmed.ncbi.nlm.nih.gov/30544686/))6 ([https://","cbCaien5xtAzEjxI","https://ap.wps.com/l/cbCaien5xtAzEjxI","pdf",5421456,16,"English","# Materials and methods\n## Routine transcriptome data download and preprocessing\n## Target prediction and gene screening\n## Functional enrichment and pathway analysis\n## Machine learning hub gene identification\n## Molecular docking and immune infiltration analysis","[{\"question\":\"What is the study’s main objective regarding narirutin and colorectal cancer?\",\"answer\":\"To identify key targets and potential mechanisms of narirutin in colorectal cancer using bioinformatics analysis and machine learning approaches.\"},{\"question\":\"Which target genes are highlighted as key narirutin targets?\",\"answer\":\"The study reports narirutin targets key genes including ABCC1, ABCG2, CA12, EPHX2, and PTGS1, which are involved in CRC progression.\"},{\"question\":\"How are binding interactions between narirutin and target proteins assessed?\",\"answer\":\"Molecular docking is performed to evaluate binding affinities between narirutin and its predicted target proteins, showing favorable binding results.\"}]","Integrative machine learning and molecular docking reveal Narirutin targets ABCC1/ABCG2 for immune microenvironment remodeling in colorectal cancer | PDF",1790086221,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cb714aed31c32e5228182a948a05d45.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5fa75eef44e8116da62a42915b7ec3dd.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f842a17e0a368984cddf986f3f9fe1c5.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7a04626ff69d11f875c2d9f5cf907a2.webp",980,1287]